Patents by Inventor Jeong M. KIM

Jeong M. KIM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190194339
    Abstract: The present invention describes combination therapy comprising an OX40 binding agonist and an agent that decreases or inhibits TIGIT expression and/or TIGIT activity and methods for use thereof, including methods of treating conditions where enhanced immunogenicity is desired, such as increasing tumor immunogenicity for the treatment of cancer or chronic infection.
    Type: Application
    Filed: June 26, 2018
    Publication date: June 27, 2019
    Inventors: Jeong M. Kim, Jane L. Grogan
  • Publication number: 20190169304
    Abstract: The present invention describes combination therapy comprising an OX40 binding agonist and an agent that decreases or inhibits TIGIT expression and/or TIGIT activity and methods for use thereof, including methods of treating conditions where enhanced immunogenicity is desired, such as increasing tumor immunogenicity for the treatment of cancer or chronic infection.
    Type: Application
    Filed: February 8, 2019
    Publication date: June 6, 2019
    Inventors: Jeong M. Kim, Jane L. Grogan
  • Publication number: 20160152720
    Abstract: The present invention describes combination therapy comprising an OX40 binding agonist and an agent that decreases or inhibits TIGIT expression and/or TIGIT activity and methods for use thereof, including methods of treating conditions where enhanced immunogenicity is desired, such as increasing tumor immunogenicity for the treatment of cancer or chronic infection.
    Type: Application
    Filed: October 29, 2015
    Publication date: June 2, 2016
    Inventors: Jeong M. KIM, Jane L. GROGAN